MedPath

Manual Ankle Therapy on Fear of Falls, Range of Motion, and Functionality and Stability in Geriatric Patients

Not Applicable
Completed
Conditions
Old Age; Atrophy
Interventions
Other: Control
Other: Experimental
Registration Number
NCT05859685
Lead Sponsor
Universidad Católica San Antonio de Murcia
Brief Summary

The range of movement of the ankle decreases with age and the plantar arch decreases, adopting a more pronated position of the foot.

The main objective is to analyze the effectiveness of manual therapy using ankle joint techniques in geriatric patients.

Randomized, double-blind clinical trial with follow-up period. Subjects will be assigned to control and experimental groups using a data analysis tool (Excel).

The dependent variable will be the fear of falls. The secondary variables will be the range of movement in dorsiflexion of the ankle, and the functionality and stability of the lower limbs.

Three evaluations will be carried out. A baseline measurement before the start of the study (T0), after the intervention (T1) and after a 3-week follow-up period (T2).

A manual therapy protocol will be carried out, lasting 3 weeks with 1 weekly session. Each session will last 10 minutes. The patients included in the experimental group will undergo the following manual therapy techniques: talus dorsal sliding technique and joint technique in "8" on the Lisfranc and Chopart joints. The patients included in the control group underwent the same techniques as those indicated for the experimental group, but without sliding or placing joint tension. The periodicity and times of administration will be the same

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Subjects older than 65 years
  • Subjects of both sexes
  • With impaired balance and gait
  • With joint limitation of ankle dorsiflexion
  • With established functionality or stability deficits (for example, who need third parties or technical aids to walk (crutches))
Exclusion Criteria
  • People with cognitive impairment that prevents their collaboration in the intervention and the different evaluations
  • People with inability to stand
  • People who have not given their written consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupControlThe patients included in the control group underwent the same techniques as those indicated for the experimental group, but without sliding or placing joint tension. The periodicity and times of administration will be the same
Experimental groupExperimentalThe patients included in the experimental group will undergo the following manual therapy techniques: * Talar dorsal sliding technique. A dorsal mobilization of the talus will be performed, with the patient in the supine position and dorsiflexion of the ankle, without pain or discomfort. The physiotherapist will exercise an anteroposterior mobilization of the talus, with a dorsal glide * Mulligan movement mobilization technique: The patient will be in a standing position, with the ankle to be treated forward. You will be given an aid or support in the upper extremity to maintain stability.
Primary Outcome Measures
NameTimeMethod
Change from baseline fear of falls after treatment and at 3 three weeksScreening visit, within the first seven days after treatment and after three weeks follow-up

With the Short Falls Efficacy Scale-International, the confidence and ability of a person to avoid a fall while performing basic activities of daily living will be evaluated. The Spanish version of this instrument has shown high reliability (α\>0.87). It consists of 7 items with a score of 7 to 28 points (higher scores indicate less confidence and ability).

Secondary Outcome Measures
NameTimeMethod
Change from baseline ankle range of motion after treatment and at 3 three weeksScreening visit, within the first seven days after treatment and after three weeks follow-up

The range of movement of the ankle will be measured with a goniometer, following the protocol of Martin et al. The axis will be placed at the lower vertex of the lateral malleolus, the fixed arm parallel to the longitudinal midline of the leg and the mobile arm parallel to the longitudinal midline of the fifth metatarsal. This instrument has shown high reliability (ICCC=0.8-0.9). The higher the graduation, the greater range of motion

Change from baseline functionality after treatment and at 3 three weeksScreening visit, within the first seven days after treatment and after three weeks follow-up

The 2-Minutes Walking Test (2MWT) will be used. It will be carried out in a closed corridor, with a length of 30 m delimited between cones. Before the test, participants must rest for at least 10 minutes. Subsequently, they will be told that they must walk the circuit around the cones as fast as possible, but without running, for 2 minutes. They will be allowed to use aids to walk, slow down or stop to rest if necessary. The distance traveled at the end of the 2 minutes will be recorded by the evaluator. This instrument has shown excellent test-retest reliability (ICC = 0.97)

Change from baseline biomechanical analysis of gait and balance after treatment and at 3 three weeksScreening visit, within the first seven days after treatment and after three weeks follow-up

It will be evaluated with an Rs Scan® pressure platform and FootScan® pressure measurement system. This device measures plantar pressure using an X-Y array of resistive pressure sensitive sensors that are sequentially scanned. The system records pressure data when the subject is standing or walking on the platform. The measurements will be made with the basic platform of 0.5m with 4096 sensors with resistive technology and 300Hz data acquisition frequency. The biomechanics of gait will be analyzed with the analysis of the probes and the static balance in a time of 30 seconds.

Trial Locations

Locations (1)

Universidad Católica San Antonio de Murcia

🇪🇸

Murcia, Spain

© Copyright 2025. All Rights Reserved by MedPath